Global Aptamers Market By Segment ( Nucleic Acid Aptamer, Peptide Aptamer), – By Application ( Diagnostics, Therapeutics, Research & Development)-Global Industry Analysis, Size, Share, Growth, Trends, and Forecast Report. Segmented Competitive Landscape and Future Outlook, 2017 – 2030.

Key Highlights of the Report

• The aptamers market is projected to reach sales of USD 858.74 million by 2030, displaying a compound annual boom fee (CAGR) of 17.08% throughout the forecast from 2023 to 2030.
• North America dominates the aptamers market with over 40% marketplace share, driven by large studies and improvement activities, technological advancements, and key marketplace gamers.
• The nucleic acid section holds the biggest market proportion, accounting for over two-thirds of the marketplace, due to its enormous programs in therapeutics, diagnostics, and studies.
• The growing adoption of aptamers in therapeutics, the developing call for personalized remedy, technological advancements in aptamer development, and growing studies and improvement sports are the key drivers propelling marketplace growth.
• However, stringent regulatory necessities and high improvement fees are massive restraints for the aptamers marketplace.
  
• Expansion into diagnostic programs and the capability for collaboration and partnerships present profitable possibilities for marketplace players within the coming years.

Market Overview

The aptamers marketplace has witnessed a great boom in recent years, pushed through the growing adoption of aptamers in therapeutics, diagnostics, and studies applications. Aptamers, or chemical or artificial antibodies, are single-stranded DNA or RNA molecules that bind to precise objectives, which include proteins, small molecules, cells, and pathogens, with high affinity and specificity.

Aptamers are selected via a process called Systematic Evolution of Ligands with the aid of Exponential Enrichment (SELEX), wherein libraries of randomized oligonucleotides are iteratively screened and enriched for sequences that bind to the desired goals. The ensuing aptamers can then be optimized, modified, and conjugated to enhance their homes and permit specific programs.

The aptamers marketplace is segmented primarily based on the kind of aptamers, programs, end-users, and areas. By kind, the marketplace is categorized into nucleic acid aptamers (DNA and RNA) and peptide aptamers. Nucleic acid aptamers hold the biggest marketplace share, accounting for over -thirds of the market.

These aptamers provide several advantages, including high stability, ease of synthesis, and numerous goal-binding abilities. Although much less generic, peptide aptamers are gaining traction due to their potential to goal protein-protein interactions and modulate intracellular signalling pathways.

The packages of aptamers span numerous fields, such as therapeutics, diagnostics, studies, and development. In therapeutics, aptamers are evolved as novel tablets and biologics for treating diverse sicknesses. They can target precise ailment markers, inhibit protein-protein interactions, modulate enzymatic activities, and deliver therapeutic payloads. Aptamer-based therapeutics have shown promise in oncology, cardiovascular problems, infectious sicknesses, and autoimmune situations.

In diagnostics, aptamers are applied as molecular recognition factors in diverse assay formats, such as biosensors, point-of-care gadgets, and imaging techniques. Their excessive specificity and sensitivity allow the detection and quantification of ailment markers, pathogens, and biomarkers with advanced accuracy and reliability. Aptamer-based diagnostics can revolutionize disorder prognosis, patient monitoring, and precision medication.

Furthermore, aptamers play an important function in studies and development. They are treasured equipment for reading protein structure and function, identifying novel drug goals, and facilitating drug discovery and development. Aptamers can be employed in target validation, goal identity, target engagement assays, and excessive-throughput screening, permitting faster and greater efficient drug improvement techniques.

Geographically, North America holds the largest marketplace proportion inside the aptamers marketplace, accounting for over 40%. The vicinity’s dominance can be attributed to factors together with great studies and development sports, technological improvements, and the presence of key market players. The properly set up healthcare infrastructure, favorable regulatory environment, and supportive authority’s initiatives similarly contribute to increasing the aptamers marketplace in North America.

Europe is the second-largest marketplace for aptamers, pushed via growing studies investments, collaborations between instructional institutions and enterprises, and the growing cognizance of customized medicine.

The Asia Pacific region is predicted to witness sizable growth in the forecast length, mainly because of the growing healthcare expenditure, cognisance of approximately advanced therapeutics and diagnostics, and a large affected person pool. Emerging economies, including China and India, are projected to contribute appreciably to marketplace growth inside the place.

The aptamers marketplace is very aggressive, with several key gamers working in the industry. These players are engaged in significant studies and development activities, strategic collaborations, mergers and acquisitions, and product launches to advantage an aggressive aspect. Some distinguished gamers in the aptamers market include NeoVentures Biotechnology Inc., Aptamer Sciences Inc., NOXXON Pharma, Base Pair Biotechnologies, Aptagen, LLC, and Vivonics, Inc.

Executive Summary

The aptamers marketplace has witnessed huge growth in recent years and is projected to continue its upward trajectory inside the forecast duration from 2023 to 2030. Aptamers, called chemical or synthetic antibodies, are unmarried-stranded DNA or RNA molecules that bind to particular goals with excessive affinity and specificity. Their unique houses cause them to treasured gear in various fields, including therapeutics, diagnostics, research, and improvement.

Several factors drive the market, including the growing adoption of aptamers in therapeutics. Aptamers provide blessings over traditional antibodies, higher target specificity, decreased immunogenicity, and ease of synthesis and modification. They are being utilized in developing novel pills and biologics to deal with numerous sicknesses, such as cancer, cardiovascular problems, infectious diseases, and autoimmune situations.

Moreover, the growing call for personalized medication is boosting the adoption of aptamers. These molecules can be engineered to goal characterise patients’ specific genetic profiles, enabling personalized healing procedures and diagnostics. Aptamers can potentially revolutionize the healthcare industry by presenting tailor-made treatments with better efficacy and fewer aspect effects.

Technological advancements in aptamer development also are propelling market growth. Ongoing research focuses on improving aptamer selection methods, improving their balance and pharmacokinetic residences, and exploring novel changes and conjugation techniques. These improvements contribute to the expanding scope of aptamers in various applications and the ride market boom.

Additionally, the rising research and improvement sports in aptamers fuel marketplace expansion. Academic establishments, studies agencies, and biotechnology organizations actively observe and expand novel aptamers with diverse functionalities. The growing know-how of aptamer biology and the improvement of strong selection and synthesis strategies facilitate the invention and alertness of aptamers in new regions.

However, the aptamers marketplace faces positive demanding situations and restraints. Stringent regulatory necessities governing the approval and commercialization of aptamer-primarily based merchandise can appreciably preclude marketplace increase.

The regulatory landscape for aptamers is still evolving, and ensuring protection, efficacy, and fine requirements stays essential for marketplace gamers. Compliance with regulatory guidelines requires an extensive investment of time, sources, and expertise, posing a barrier to marketplace access.

Moreover, excessive improvement expenses pose a mission for the aptamers market. Aptamer improvement entails vast research, optimization, and validation tactics, which incur massive costs. The charges related to the synthesis, modification, and purification of aptamers and preclinical and medical checking out may be great, restricting the accessibility and affordability of aptamer-based products.

Despite those demanding situations, the aptamers marketplace offers several possibilities for enlargement and growth. One such opportunity lies within the enlargement of diagnostic programs. Aptamers have verified superb capacity in diagnostic assays, including biosensors, factor-of-care gadgets, and imaging strategies.

Their high specificity and sensitivity cause them to be best for detecting and quantifying ailment markers, pathogens, and biomarkers. Integrating aptamers into diagnostic structures can allow fast and correct detection, paving the way for advanced disorder diagnosis and monitoring.

Furthermore, collaboration and partnerships present a promising possibility for marketplace players. Collaboration among academia, enterprise, and regulatory bodies can foster understanding change, aid sharing, and technology transfer, accelerating the improvement and commercialization of aptamer-primarily based products.

Partnerships among pharmaceutical agencies, diagnostic producers, and research businesses can facilitate translating aptamer studies into clinically viable products and beautify marketplace penetration.

Market Insights

Current Market Trends inside the Global Aptamers Market

The worldwide aptamers marketplace has been experiencing a tremendous boom in recent years. Aptamers are short, single-stranded DNA or RNA molecules that can bind particularly to goal molecules. They are rising as a promising opportunity for antibodies in various applications, which include diagnostics, therapeutics, and research. Several market trends are riding the increase of the worldwide aptamers marketplace.

Increasing Demand for Personalized Medicine:

Personalized medicinal drug is gaining global traction as it offers tailor-made treatments based on a person’s genetic makeup. Aptamers play an important role in personalized medication by enabling the targeted transport of medicine to precise cells or tissues. The potential of aptamers to bind to precise objectives with excessive affinity and selectivity makes them the best applicants for personalized cures, driving their call for inside the market.

Growing Applications in Diagnostics:

Aptamers are extensively used in diagnostic applications due to their high specificity and sensitivity. They may be effortlessly synthesized and labelled with various tags for detection functions. Aptamer-based assays are being evolved to detect numerous objectives, which include proteins, small molecules, and pathogens. The growing incidence of diseases, including most cancers and infectious diseases, is fueling the call for aptamer-based diagnostic checks, contributing to a market boom.

Rising Focus on Research and Development:

The aptamers market is witnessing tremendous investments in research and development activities. Academic establishments, pharmaceutical companies, and biotechnology companies are actively exploring the ability of aptamers in diverse packages.

Ongoing research efforts goal to amplify the range of goals that aptamers can bind to and improve their balance and pharmacokinetic homes. These advancements are expected to power the adoption of aptamers in each research and medical setting.

Favourable Regulatory Environment:

Regulatory corporations across the globe are recognizing the capability of aptamers and streamlining the approval processes for aptamer-based total merchandise. For example, the USA Food and Drug Administration (FDA) has authorized the first aptamer-based healing, Macugen, to treat age-associated macular degeneration. Such regulatory support encourages the development of aptamer-based products and helps the market increase.

Technological Advancements in Aptamer Selection:

The conventional approach of aptamer choice, the systematic evolution of ligands using exponential enrichment (SELEX), has obstacles in phrases of time and fee. However, advancements in aptamer choice technologies, consisting of next-generation sequencing and excessive-throughput screening techniques, have overcome those barriers. These technological advancements have accelerated the discovery and improvement of aptamers, thereby riding market increase.

Collaborations and Partnerships:

The aptamers marketplace is witnessing multiplied collaborations and partnerships among educational establishments, studies companies, and pharmaceutical groups. These collaborations aim to combine various stakeholders’ expertise to boost aptamer-primarily based studies and product improvement. Collaborative efforts beautify the knowledge alternate and accelerate the commercialization of aptamer-based totally products, fostering market increase.

Growing Demand for Biosensors:

Aptamers are extensively used to come across various analytes in biosensors. Biosensors offer rapid, touchy, and selective detection of target molecules and discover applications in healthcare, environmental monitoring, and food safety.

The increasing call factor-of-care testing and the need for fast and correct analysis drive the adoption of aptamer-primarily based biosensors. This fashion is expected to keep driving the boom of the aptamers marketplace.

Key Players and Competitive Landscape within the Global Aptamers Market

The global aptamers marketplace is incredibly aggressive, with numerous key gamers running inside the industry. To reinforce their market function, these companies actively interact in studies and development, strategic collaborations, and mergers and acquisitions.

Here are some of the key players in the worldwide aptamers market:

1.      NeoVentures Biotechnology Inc.:

NeoVentures Biotechnology is a main player in the aptamers marketplace, imparting an extensive range of aptamer-based services and products. The employer specialises in developing aptamers for healing and diagnostic programs and has a strong pipeline of candidates underneath development.

2.      Aptamer Sciences Inc.:

Aptamer Sciences is a biotechnology enterprise specialising in developing and commercializing aptamer-primarily based products. The enterprise’s portfolio includes aptamer-primarily based therapeutics, diagnostics, and studies gear. Aptamer Sciences collaborates with instructional establishments and pharmaceutical groups to boost product improvement.

3.      Aptagen, LLC:

Aptagen is a biotechnology agency that offers custom aptamer development services. The employer gives a comprehensive range of aptamer choice, optimization, and characterization offerings to meet the unique requirements of its customers. Aptagen’s know-how lies in growing aptamers for healing and diagnostic packages.

4.      Base Pair Biotechnologies, Inc.:

Base Pair Biotechnologies is a leading aptamer discovery and improvement carrier provider. The organization utilizes its proprietary platform era, known as 3DNA™, to swiftly discover high-affinity aptamers. Base Pair Biotechnologies collaborates with pharmaceutical and diagnostic agencies to broaden aptamer-based products.

5.      NOXXON Pharma AG:

NOXXON Pharma is a biotechnology business enterprise specializing in growing Spiegelmers®, a category of aptamer-like molecules. Spiegelmers are artificial, replicate-photo oligonucleotides with high binding affinity and specificity. NOXXON Pharma is engaged in developing Spiegelmers for healing packages.

6.      Vivonics, Inc.:

Vivonics is an organization that specialises in growing aptamer-based biosensors and diagnostics. The company’s proprietary platform, known as AptaSense™, enables the rapid detection of goal molecules using aptamer-based sensors. Vivonics collaborates with healthcare and diagnostic businesses to commercialize its biosensing technologies.

7.      SomaLogic, Inc.:

SomaLogic is a main company of proteomics technologies, along with aptamer-based proteomic assays. The organization’s proprietary technology, referred to as SOMAmer® (Slow Off-price Modified Aptamer), concurrently enables the size of lots of proteins. SomaLogic collaborates with pharmaceutical organizations and studies institutions for biomarker discovery and validation.

These key gamers inside the global aptamers marketplace put money into research and development sports, expand their product portfolios, and collaborate with stakeholders to preserve a competitive facet. The market is anticipated to witness multiplied opposition as new gamers enter the distance and improvements in aptamer technologies preserve power innovation.

Market Drivers

The aptamers market is pushed by several key factors contributing to its increase and growth. These drivers propel the adoption of aptamers in various applications and gas market demand.

The essential marketplace drivers encompass:

Increasing Adoption of Aptamers In Therapeutics

Aptamers offer numerous blessings over conventional antibodies within the field of therapeutics. They exhibit excessive goal specificity, low immunogenicity, and simplicity of synthesis and amendment. These properties cause them to be appealing applicants for developing novel capsules and biologics.

Aptamers can goal-specific sickness markers, inhibit protein-protein interactions, modulate enzymatic activities, and deliver healing payloads. The ability to lay out aptamers with particular binding affinity and specificity for a selected target allows the improvement of personalized therapies.

The growing attractiveness of aptamers as therapeutic sellers throughout various sicknesses, including cancer, cardiovascular disorders, infectious illnesses, and autoimmune conditions, drives their adoption within the pharmaceutical industry.

Growing Demand for Personalized Medicine

Personalized medicine is a rising technique that aims to offer tailor-made treatments based on individual patients’ precise genetic profiles, way of life elements, and sickness traits. Aptamers play a crucial role in personalized medicine because they can mainly bind to hobby objectives. By designing aptamers that concentrate on unique disorder markers or genetic variations, healthcare providers can provide greater specific and effective remedies.

Aptamers allow the development of companion diagnostics, which aid in affected person stratification, remedy choice, and treatment response tracking. The increasing demand for personalized medicine, pushed by the want for greater focused and green therapies, is fueling the adoption of aptamers in the healthcare enterprise.

Technological Advancements in Aptamer Development

Technological improvements in aptamer development are improving their properties and expanding their programs. Researchers constantly discover new methods and strategies to enhance the aptamer choice process, decorate balance, optimize pharmacokinetic houses, and allow focused delivery. Novel changes and conjugation techniques are being developed to enhance aptamer’s overall performance, amplify their 1/2-lifestyles, and decorate their healing efficacy.

Advancements in excessive-throughput screening strategies, which include subsequent-era sequencing, allow fast identity and optimization of aptamers with preferred homes. Integrating nanotechnology and biosensor platforms with aptamers opens new opportunities for touchy and specific detection methods. These technological advancements force the development of extra sophisticated aptamers and make their use bigger in numerous applications, fueling the marketplace boom.

Rising Research and Development Activities

The aptamers market uses widespread studies and improvement activities performed by educational establishments, research agencies, and biotechnology companies. Researchers are actively reading aptamer biology, exploring new targets, and growing progressive aptamer-primarily based therapeutics and diagnostics.

The growing understanding of aptamer structure-function relationships, coupled with improvements in choice strategies, synthesis strategies, and characterization tools, is accelerating the discovery and alertness of aptamers.

The multiplied consciousness on translational research, preclinical and scientific research, and proof-of-concept trials are paving the way for the commercialization of aptamer-based products. The rising research and improvement activities contribute to the growth of the aptamers marketplace via riding innovation and fostering the invention of novel aptamers with diverse functionalities.

Market Restraints

While the aptamers marketplace is famous for promising growth ability, certain factors act as restraints and pose challenges for market gamers. Understanding these restraints is important for devising strategies to triumph over them.

The most important marketplace restraints consist of the following:

Stringent Regulatory Requirements

The regulatory landscape governing aptamers remains evolving, and stringent necessities are near to make certain aptamer-based merchandise’ protection, efficacy, and exceptional. Obtaining regulatory approvals for aptamer-primarily based therapeutics and diagnostics involves rigorous evaluation, preclinical trying out, and medical trials.

Compliance with the regulatory tips and demonstrating the safety and effectiveness of aptamers can be time-consuming and expensive. The complex regulatory surroundings greatly hinder market access and product commercialization. Market gamers want to invest good-sized resources and knowledge to navigate the regulatory panorama and achieve important approvals, which could restrict the growth of the aptamers market.

High Development Costs

Aptamer development encompasses various levels, including target identification, aptamer choice, optimization, synthesis, modification, and preclinical and clinical checking out. Each stage incurs enormous research and development fees, labour and device charges, and charges related to preclinical and clinical research.

The excessive fee for aptamer improvement poses a mission specifically for small and medium-sized establishments with constrained financial resources. The huge funding required to bring aptamer-based products to the marketplace restricts accessibility and affordability, hindering the market boom. The fee-extensive nature of aptamer improvement necessitates strategic partnerships, funding assistance, and efficient resource management to mitigate the economic burden and foster market enlargement.

Market Opportunities

The aptamers market affords several opportunities for marketplace gamers to capitalize on and power in addition increase. These possibilities arise from rising trends, unmet wishes, and evolving market dynamics. Exploring these possibilities can assist market players in making their presence bigger and capturing a bigger marketplace proportion.

The key marketplace possibilities include the following:

Expansion into Diagnostic Applications

While aptamers have won extensive traction in therapeutics, there’s tremendous capability for their enlargement into diagnostic programs. Aptamers offer several blessings as molecular popularity elements in diagnostic assays, which include biosensors, factor-of-care gadgets, and imaging strategies.

The high affinity and specificity of aptamers enable the touchy and specific detection of ailment markers, pathogens, and biomarkers. Aptamer-primarily based diagnostics can revolutionize sickness diagnosis, allowing early detection, correct quantification, and actual-time monitoring.

Market players can explore the mixing of aptamers into diagnostic systems, develop novel diagnostic assays, and collaborate with diagnostic manufacturers to faucet into this expanding marketplace phase. The expansion into diagnostic applications can diversify sales streams and contribute to stepped-forward patient care and sickness management.

Collaboration and Partnerships

Collaboration among academia, enterprise, and regulatory bodies gives a substantial opportunity for market gamers within the aptamers market. Collaborative efforts can facilitate know-how alternate, aid sharing, and era switch, main to expanded development and commercialization of aptamer-based products.

Partnerships among pharmaceutical companies, diagnostic producers, and research groups can leverage complementary understanding and talents, enabling the interpretation of aptamer studies into clinically feasible products. Collaborative tasks also can assist in overcoming regulatory demanding situations, pool resources, and percentage dangers, main to a faster time-to-market and elevated marketplace penetration.

Market players must actively seek collaboration possibilities, establish strategic partnerships, and interact in consortia to leverage collective strengths and capitalize on the considerable capability of aptamers.

Exploration of Niche Applications

While the aptamers marketplace is expanding throughout diverse fields, untapped areas of interest applications offer growth opportunities. Market gamers can awareness of identifying and exploring niche regions wherein aptamers can provide particular solutions. This should focus on particular diseases or underserved situations or address unmet desires in uniquely affected populations.

By leveraging the advantages of aptamers, consisting of target specificity, modifiability, and ease of synthesis, market gamers can broaden tailored solutions for niche programs. Strategic investments in research and improvement, collaboration with key opinion leaders, and an understanding of marketplace dynamics can help identify and capitalize on this area of interest opportunities.

Advancements in Aptamer Delivery Systems

Aptamer-primarily based therapeutics require efficient shipping systems to reach their goals in vivo. Advancements in drug transport technologies present an opportunity for market players to enhance the healing ability of aptamers. Nanoparticle-primarily based shipping systems, liposomes, exosomes, and different nanocarriers can facilitate the centred delivery of aptamers, enhance their balance, lengthen their stream time, and enhance their cell uptake.

Market players can put money into studies and development efforts to design and optimize aptamer shipping structures, ensuring effective and managed release on the desired websites. Improving modern transport structures can free up new possibilities for aptamer-based therapeutics, make their applicability bigger, and improve patient effects.

Why Buy This Report

This report presents complete insights into the global aptamers market, offering valuable records for marketplace gamers, buyers, researchers, and stakeholders.

The key reasons to shop for this report are as follows:

• The report offers an in-depth evaluation of the market length and forecast for the aptamers marketplace from 2017 to 2030.
• It identifies and analyzes the key developments shaping the aptamers marketplace.
• The report highlights the important drivers and restraints influencing the growth of the aptamers marketplace.
• It offers an in-depth analysis of the competitive landscape of the aptamers marketplace, including the profiles of key players.
• The report identifies and explores the possibilities in the aptamers market.
•  It outlines the regulatory environment governing aptamers and discusses the evolving regulations.
• Based on the findings and analysis, the report gives strategic guidelines for market players to enhance their marketplace presence and capitalize on the opportunities in the aptamers market.

CHAPTER NO. 1 : INTRODUCTION 12

1.1. Report Description 12

1.1.1. Purpose of the Report 12

1.1.2. USP & Key Offerings 12

1.2. Key Benefits for Stakeholders 12

1.3. Target Audience 13

1.4. Report Scope 13

 

CHAPTER NO. 2 : EXECUTIVE SUMMARY 16

2.1. Aptamers Market Snapshot 16

2.2. Global Aptamers Market, 2017 – 2030  (USD Million) 18

2.1. Insights from Primary Respondents 18

 

CHAPTER NO. 3 : COVID 19 IMPACT ANALYSIS 19

3.1. Impact Assessment of COVID-19 Pandemic, By Region 19

 

CHAPTER NO. 4 : APTAMERS MARKET – INDUSTRY ANALYSIS 20

4.1.Introduction20

4.2. Market Drivers 21

4.2.1. Increasing adoption of aptamers in therapeutics 21

4.2.2. Growing demand for personalized medicine 22

4.3. Market Restraints 22

4.3.1. Restraining Factor Analysis 22

4.4. Market Opportunities 23

4.4.1. Market Opportunity Analysis 23

4.5. Porter’s Five Forces Analysis 23

4.6. Value Chain Analysis 24

 

CHAPTER NO. 5 : KEY INVESTMENT POCKETS ANALYSIS 25

5.1. Top Investment Pockets 25

5.1.1.1. Aptamers Market Attractiveness Analysis, By Type 25

5.1.1.2. Aptamers Market Attractiveness Analysis, By Application 25

5.2. Product Life Cycle Analysis 26

5.3. Incremental Revenue Growth Opportunity, 2023 – 2030 27

5.3.1. Type 27

5.3.2. Application 27

 

CHAPTER NO. 6 : MARKET POSITIONING OF KEY PLAYERS 28

6.1. Company Market Share Analysis –2020 and 2022 28

6.1.1. Global Aptamers Market: Company Market Share, 2022 28

6.1.2. Global Aptamers Market: Company Market Share, 2022 28

6.1. Global Aptamers Market Company Volume Market Share, 2022 29

6.2. Global Aptamers Market Company Revenue Market Share, 2022 30

6.3. Market Position of Key Players 2022 31

6.3.1. Market Position of Key Players, 2022 31

6.4. Strategic Developments 32

6.4.1. Acquisitions & Mergers 32

6.4.2. New Product Launch 32

6.4.3. Regional Expansion 32

 

CHAPTER NO. 7 : APTAMERS MARKET – BY TYPE SEGMENT ANALYSIS 33

7.1. Aptamers Market Overview, by Type Segment 33

7.1.1. Global Aptamers Market Revenue Share, By Type, 2022 & 2030 34

7.2. Nucleic Acid Aptamer 35

7.2.1. Global Nucleic Acid Aptamer Aptamers Market Revenue, By Region, 2017 – 2022 (USD Million) 35

7.3. Peptide Aptamer 36

7.3.1. Global Nucleic Acid Aptamer Aptamers Market Revenue, By Region, 2017 – 2022 (USD Million) 36

 

CHAPTER NO. 8 : APTAMERS MARKET – BY APPLICATION SEGMENT ANALYSIS 40

8.1. Aptamers Market Overview, by Application Segment 40

8.1.1. Global Aptamers Market Revenue Share, By Application, 2022 & 2030 41

8.2. Diagnostics 42

8.2.1. Global Aptamers for Diagnostics Market Revenue, By Region, 2017 – 2022 (USD Million) 42

8.3. Therapeutics 43

8.3.1. Global Aptamers for Therapeutics Market Revenue, By Region, 2017 – 2022 (USD Million) 43

8.4. Research & Development 44

8.4.1. Global Aptamers for Research & Development Market Revenue, By Region, 2017 – 2022 (USD Million) 44

8.5. Others 45

8.5.1. Global Aptamers for Others Market Revenue, By Region, 2017 – 2022 (USD Million) 45

 

CHAPTER NO. 9 : APTAMERS MARKET – REGIONAL ANALYSIS 47

9.1. Aptamers Market Overview, by Region Segment 47

9.1.1. Global Aptamers Market Revenue Share, By Region, 2022 & 2030 48

9.1.2. Global Aptamers Market Revenue, By Region, 2017 – 2022 (USD Million) 49

9.1.3. Global Aptamers Market Revenue, By Type, 2017 – 2022 (USD Million) 50

9.1.4. Global Aptamers Market Revenue, By Application, 2017 – 2022 (USD Million) 51

9.2. North America 52

9.2.1. North America Aptamers Market Revenue, By Country, 2017 – 2022 (USD Million) 53

9.2.2. North America Aptamers Market Revenue, By Type, 2017 – 2022 (USD Million) 54

9.2.3. North America Aptamers Market Revenue, By Application, 2017 – 2022 (USD Million) 55

9.2.4. U.S. 56

9.2.5. Canada 56

9.2.6. Mexico 56

9.3. Europe 57

9.3.1. Europe Aptamers Market Revenue, By Country, 2017 – 2022 (USD Million) 58

9.3.2. Europe Aptamers Market Revenue, By Type, 2017 – 2022 (USD Million) 59

9.3.3. Europe Aptamers Market Revenue, By Application, 2017 – 2022 (USD Million) 60

9.3.4. UK 61

9.3.5. France 61

9.3.6. Germany 61

9.3.7. Italy 61

9.3.8. Spain 61

9.3.9. Russia 61

9.3.10. BENELUX 61

9.3.11. Sweden 61

9.3.12. Denmark 61

9.3.13. Poland 61

9.3.14. Austria 61

9.3.15. Rest of Europe 61

9.4. Asia Pacific 62

9.4.1. Asia Pacific Aptamers Market Revenue, By Country, 2017 – 2022 (USD Million) 63

9.4.2. Asia Pacific Aptamers Market Revenue, By Type, 2017 – 2022 (USD Million) 64

9.4.3. Asia Pacific Aptamers Market Revenue, By Application, 2017 – 2022 (USD Million) 65

9.4.4. China 66

9.4.5. Japan 66

9.4.6. South Korea 66

9.4.7. India 66

9.4.8. Thailand 66

9.4.9. Indonesia 66

9.4.10. Vietnam 66

9.4.11. Malaysia 66

9.4.12. Philippines 66

9.4.13. Taiwan 66

9.4.14. Rest of Asia Pacific 66

9.5. Latin America 67

9.5.1. Latin America Aptamers Market Revenue, By Country, 2017 – 2022 (USD Million) 68

9.5.2. Latin America Aptamers Market Revenue, By Type, 2017 – 2022 (USD Million) 69

9.5.3. Latin America Aptamers Market Revenue, By Application, 2017 – 2022 (USD Million) 70

9.5.4. Brazil 71

9.5.5. Argentina 71

9.5.6. Colombia 71

9.5.7. Chile 71

9.5.8. Peru 71

9.5.9. Rest of Latin America 71

9.6. The Middle-East 72

9.6.1. Middle East Aptamers Market Revenue, By Country, 2017 – 2022 (USD Million) 73

9.6.2. Middle East Aptamers Market Revenue, By Type, 2017 – 2022 (USD Million) 74

9.6.3. Middle East Aptamers Market Revenue, By Application, 2017 – 2022 (USD Million) 75

9.6.4. GCC Countries 76

9.6.5. Israel 76

9.6.6. Turkey 76

9.6.7. Iran 76

9.6.8. Rest of Middle East & Africa 76

9.7. Africa 77

9.7.1. Africa Aptamers Market Revenue, By Country, 2017 – 2022 (USD Million) 78

9.7.2. Africa Aptamers Market Revenue, By Type, 2017 – 2022 (USD Million) 79

9.7.3. Africa Aptamers Market Revenue, By Application, 2017 – 2022 (USD Million) 80

9.7.4. South Africa 81

9.7.5. Egypt 81

9.7.6. Nigeria 81

9.7.7. Algeria 81

9.7.8. Morocco 81

9.7.9. Rest of Africa 81

 

CHAPTER NO. 10 : COMPANY  PROFILES 82

10.1. SomaLogic 82

10.1.1. Company Overview 82

10.1.2. Product Portfolio 82

10.1.3. Financial Overview 82

10.2. Aptamer Group 83

10.3. Aptadel Therapeutics 83

10.4. Base Pair Biotechnologies 83

10.5. Noxxon Pharma 83

10.6. Vivonics Inc. 83

10.7. Aptagen, LLC 83

10.8. TriLink Biotechnologies 83

10.9. Altermune LLC 83

10.10. AM Biotechnologies 83

10.11. NeoVentures Biotechnology Inc. 83

10.12. Aptus Biotech S.L. 83

10.13. TriLink BioTechnologies, Inc. 83

10.14. Archemix Corp. 83

 

CHAPTER NO. 11 : RESEARCH METHODOLOGY 84

11.1. Research Methodology 84

11.2. Phase I – Secondary Research 85

11.3. Phase II – Data Modeling 85

11.3.1. Company Share Analysis Model 86

11.3.2. Revenue Based Modeling 86

11.4. Phase III – Primary Research 87

11.5. Research Limitations 88

11.5.1. Assumptions 88

 

List of Figures

FIG NO. 1. Global Aptamers Market Volume & Revenue, 2017 – 2030  (USD Million) 18

FIG NO. 2. Porter’s Five Forces Analysis for Global Aptamers Market 23

FIG NO. 3. Value Chain Analysis for Global Aptamers Market 24

FIG NO. 4. Market Attractiveness Analysis, By Type 25

FIG NO. 5. Market Attractiveness Analysis, By Application 25

FIG NO. 6. Product Life Cycle Analysis 26

FIG NO. 7. Incremental Revenue Growth Opportunity by Type 27

FIG NO. 8. Incremental Revenue Growth Opportunity by Application 27

FIG NO. 9. Company Share Analysis, 2020 28

FIG NO. 10. Company Share Analysis, 2022 28

FIG NO. 11. Aptamers Market – Company Volume  Market Share, 2022 29

FIG NO. 12. Aptamers Market – Company Revenue Market Share, 2022 30

FIG NO. 13. Market Position of Key Players, 2022 31

FIG NO. 14. Global Aptamers Market Revenue Share, By Type, 2022 & 2030 34

FIG NO. 15. Global Aptamers Market for Nucleic Acid Aptamer, Volume & Revenue  (USD Million) 2017 – 2030 35

FIG NO. 16. Global Aptamers Market for Peptide Aptamer, Volume & Revenue  (USD Million) 2017 – 2030 36

FIG NO. 17. Global Aptamers Market for Type 3, Volume & Revenue  (USD Million) 2017 – 2030 37

FIG NO. 18. Global Aptamers Market for Type 4, Volume & Revenue  (USD Million) 2017 – 2030 38

FIG NO. 19. Global Aptamers Market for Type 5, Volume & Revenue  (USD Million) 2017 – 2030 39

FIG NO. 20. Global Aptamers Market Revenue Share, By Application, 2022 & 2030 41

FIG NO. 21. Global Aptamers Market for Diagnostics, Volume & Revenue  (USD Million) 2017 – 2030 42

FIG NO. 22. Global Aptamers Market for Therapeutics, Volume & Revenue  (USD Million) 2017 – 2030 43

FIG NO. 23. Global Aptamers Market for Research & Development, Volume & Revenue  (USD Million) 2017 – 2030 44

FIG NO. 24. Global Aptamers Market for Others, Volume & Revenue  (USD Million) 2017 – 2030 45

FIG NO. 25. Global Aptamers Market for Application 5, Volume & Revenue  (USD Million) 2017 – 2030 46

FIG NO. 26. Global Aptamers Market Revenue Share, By Region, 2022 & 2030 48

FIG NO. 27. North America Aptamers Market Volume & Revenue, 2017 – 2022  (USD Million) 52

FIG NO. 28. Europe Aptamers Market Volume & Revenue, 2017 – 2022  (USD Million) 57

FIG NO. 29. Asia Pacific Aptamers Market Volume & Revenue, 2017 – 2022  (USD Million) 62

FIG NO. 30. Latin America Aptamers Market Volume & Revenue, 2017 – 2022  (USD Million) 67

FIG NO. 31. The Middle-East Aptamers Market Volume & Revenue, 2017 – 2022  (USD Million) 72

FIG NO. 32. Africa Aptamers Market Volume & Revenue, 2017 – 2022  (USD Million) 77

FIG NO. 33. Research Methodology – Detailed View 84

FIG NO. 34. Research Methodology 85

 

List of Tables

TABLE NO. 1. : Global Aptamers Market: Snapshot 16

TABLE NO. 2. : Drivers for the Aptamers Market: Impact Analysis 21

TABLE NO. 3. : Restraints for the Aptamers Market: Impact Analysis 22

TABLE NO. 4. : Global Nucleic Acid Aptamer Aptamers Market Revenue, By Region, 2017 – 2022 (USD Million) 35

TABLE NO. 5. : Global Nucleic Acid Aptamer Aptamers Market Revenue, By Region, 2023– 2030 (USD Million) 35

TABLE NO. 6. : Global Nucleic Acid Aptamer Aptamers Market Revenue, By Region, 2017 – 2022 (USD Million) 36

TABLE NO. 7. : Global Nucleic Acid Aptamer Aptamers Market Revenue, By Region, 2023– 2030 (USD Million) 36

TABLE NO. 8. : Global Type 3 Aptamers Market Revenue, By Region, 2017 – 2022 (USD Million) 37

TABLE NO. 9. : Global Type 3 Aptamers Market Revenue, By Region, 2023– 2030 (USD Million) 37

TABLE NO. 10. : Global Type 4 Aptamers Market Revenue, By Region, 2017 – 2022 (USD Million) 38

TABLE NO. 11. : Global Type 4 Aptamers Market Revenue, By Region, 2023– 2030 (USD Million) 38

TABLE NO. 12. : Global Type 5 Aptamers Market Revenue, By Region, 2017 – 2022 (USD Million) 39

TABLE NO. 13. : Global Type 5 Aptamers Market Revenue, By Region, 2023– 2030 (USD Million) 39

TABLE NO. 14. : Global Aptamers for Diagnostics Market Revenue, By Region, 2017 – 2022 (USD Million) 42

TABLE NO. 15. : Global Aptamers for Diagnostics Market Revenue, By Region, 2023– 2030 (USD Million) 42

TABLE NO. 16. : Global Aptamers for Therapeutics Market Revenue, By Region, 2017 – 2022 (USD Million) 43

TABLE NO. 17. : Global Aptamers for Therapeutics Market Revenue, By Region, 2023– 2030 (USD Million) 43

TABLE NO. 18. : Global Aptamers for Research & Development Market Revenue, By Region, 2017 – 2022 (USD Million) 44

TABLE NO. 19. : Global Aptamers for Research & Development Market Revenue, By Region, 2023– 2030 (USD Million) 44

TABLE NO. 20. : Global Aptamers for Others Market Revenue, By Region, 2017 – 2022 (USD Million) 45

TABLE NO. 21. : Global Aptamers for Others Market Revenue, By Region, 2023– 2030 (USD Million) 45

TABLE NO. 22. : Global Aptamers for Application 5 Market Revenue, By Region, 2017 – 2022 (USD Million) 46

TABLE NO. 23. : Global Aptamers for Application 5 Market Revenue, By Region, 2023– 2030 (USD Million) 46

TABLE NO. 24. : Global Aptamers Market Revenue, By Region, 2017 – 2022 (USD Million) 49

TABLE NO. 25. : Global Aptamers Market Revenue, By Region, 2023– 2030 (USD Million) 49

TABLE NO. 26. : Global Aptamers Market Revenue, By Type, 2017 – 2022 (USD Million) 50

TABLE NO. 27. : Global Aptamers Market Revenue, By Type, 2023– 2030 (USD Million) 50

TABLE NO. 28. : Global Aptamers Market Revenue, By Application, 2017 – 2022 (USD Million) 51

TABLE NO. 29. : Global Aptamers Market Revenue, By Application, 2023– 2030 (USD Million) 51

TABLE NO. 30. : North America Aptamers Market Revenue, By Country, 2017 – 2022 (USD Million) 53

TABLE NO. 31. : North America Aptamers Market Revenue, By Country, 2023– 2030 (USD Million) 53

TABLE NO. 32. : North America Aptamers Market Revenue, By Type, 2017 – 2022 (USD Million) 54

TABLE NO. 33. : North America Aptamers Market Revenue, By Type, 2023– 2030 (USD Million) 54

TABLE NO. 34. : North America Aptamers Market Revenue, By Application, 2017 – 2022 (USD Million) 55

TABLE NO. 35. : North America Aptamers Market Revenue, By Application, 2023– 2030 (USD Million) 55

TABLE NO. 36. : Europe Aptamers Market Revenue, By Country, 2017 – 2022 (USD Million) 58

TABLE NO. 37. : Europe Aptamers Market Revenue, By Country, 2023– 2030 (USD Million) 58

TABLE NO. 38. : Europe Aptamers Market Revenue, By Type, 2017 – 2022 (USD Million) 59

TABLE NO. 39. : Europe Aptamers Market Revenue, By Type, 2023– 2030 (USD Million) 59

TABLE NO. 40. : Europe Aptamers Market Revenue, By Application, 2017 – 2022 (USD Million) 60

TABLE NO. 41. : Europe Aptamers Market Revenue, By Application, 2023– 2030 (USD Million) 60

TABLE NO. 42. : Asia Pacific Aptamers Market Revenue, By Country, 2017 – 2022 (USD Million) 63

TABLE NO. 43. : Asia Pacific Aptamers Market Revenue, By Country, 2023– 2030 (USD Million) 63

TABLE NO. 44. : Asia Pacific Aptamers Market Revenue, By Type, 2017 – 2022 (USD Million) 64

TABLE NO. 45. : Asia Pacific Aptamers Market Revenue, By Type, 2023– 2030 (USD Million) 64

TABLE NO. 46. : Asia Pacific Aptamers Market Revenue, By Application, 2017 – 2022 (USD Million) 65

TABLE NO. 47. : Asia Pacific Aptamers Market Revenue, By Application, 2023– 2030 (USD Million) 65

TABLE NO. 48. : Latin America Aptamers Market Revenue, By Country, 2017 – 2022 (USD Million) 68

TABLE NO. 49. : Latin America Aptamers Market Revenue, By Country, 2023– 2030 (USD Million) 68

TABLE NO. 50. : Latin America Aptamers Market Revenue, By Type, 2017 – 2022 (USD Million) 69

TABLE NO. 51. : Latin America Aptamers Market Revenue, By Type, 2023– 2030 (USD Million) 69

TABLE NO. 52. : Latin America Aptamers Market Revenue, By Application, 2017 – 2022 (USD Million) 70

TABLE NO. 53. : Latin America Aptamers Market Revenue, By Application, 2023– 2030 (USD Million) 70

TABLE NO. 54. : Middle East Aptamers Market Revenue, By Country, 2017 – 2022 (USD Million) 73

TABLE NO. 55. : Middle East Aptamers Market Revenue, By Country, 2023– 2030 (USD Million) 73

TABLE NO. 56. : Middle East Aptamers Market Revenue, By Type, 2017 – 2022 (USD Million) 74

TABLE NO. 57. : Middle East Aptamers Market Revenue, By Type, 2023– 2030 (USD Million) 74

TABLE NO. 58. : Middle East Aptamers Market Revenue, By Application, 2017 – 2022 (USD Million) 75

TABLE NO. 59. : Middle East Aptamers Market Revenue, By Application, 2023– 2030 (USD Million) 75

TABLE NO. 60. : Africa Aptamers Market Revenue, By Country, 2017 – 2022 (USD Million) 78

TABLE NO. 61. : Africa Aptamers Market Revenue, By Country, 2023– 2030 (USD Million) 78

TABLE NO. 62. : Africa Aptamers Market Revenue, By Type, 2017 – 2022 (USD Million) 79

TABLE NO. 63. : Africa Aptamers Market Revenue, By Type, 2023– 2030 (USD Million) 79

TABLE NO. 64. : Africa Aptamers Market Revenue, By Application, 2017 – 2022 (USD Million) 80

TABLE NO. 65. : Africa Aptamers Market Revenue, By Application, 2023– 2030 (USD Million) 80